<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="171717">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00860912</url>
  </required_header>
  <id_info>
    <org_study_id>IRB# 8585</org_study_id>
    <nct_id>NCT00860912</nct_id>
  </id_info>
  <brief_title>Veritas Collagen Matrix Cystocele Repair Study - Postmarketing</brief_title>
  <official_title>Veritas Collagen Matrix Cystocele Repair Study - Postmarketing Protocol #CP1004</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cleveland Clinic Florida</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Synovis Surgical Innovations</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Cleveland Clinic Florida</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the Veritas Collagen Matrix in treating female
      patients with documented occurence of Pelvic Organ Prolapse as evidenced by a cystocele.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2001</start_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the ability of the VCM to treat pelvic organ prolapse as demonstrated by improvement of cystocele as measured by a comparison of POP-Q scores pre and post surgery</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate patient satisfaction as measured by a comparison of Quality of Life questions at baseline and post surgery</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>One</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Veritas reinforcing material</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No reinforcing material</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Veritas Collagen Matrix</intervention_name>
    <description>surgical/reinforcing material</description>
    <arm_group_label>One</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is equal or greater than 18 years old

          -  Female

          -  Meets follow-up evaluation time frame

          -  Understands the nature of the procedure and has provided written informed consent

          -  Is scheduled to undergo vaginal pelvic reconstructive surgery

          -  Has &gt; 2nd degree midline cystocele

        Exclusion Criteria:

          -  Presence of severe mucosal ulceration

          -  Previous pelvic organ prolapse surgery using an implant that will affect the use of
             the VCM or affect the outcome of the study

          -  Allergy to bovine material

          -  Severe mucosal atrophy

          -  Shortened vaginal length as determined by Investigator

          -  Pregnant or intends to become pregnant during study

          -  Has a UTI

          -  Has vault prolapse &lt; 2nd degree cystocele
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillermo W Davila, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Florida</affiliation>
  </overall_official>
  <verification_date>March 2009</verification_date>
  <lastchanged_date>March 12, 2009</lastchanged_date>
  <firstreceived_date>March 12, 2009</firstreceived_date>
  <responsible_party>
    <organization>Synovis Surgical Innovations</organization>
  </responsible_party>
  <keyword>Veritas</keyword>
  <keyword>Cystocele</keyword>
  <keyword>Prolapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
    <mesh_term>Cystocele</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
